ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $46,000 | +109.1% | 26,826 | +51.3% | 0.00% | – |
Q4 2020 | $22,000 | +69.2% | 17,732 | +63.0% | 0.00% | – |
Q2 2020 | $13,000 | -40.9% | 10,876 | +2.4% | 0.00% | – |
Q4 2019 | $22,000 | -67.2% | 10,622 | -65.1% | 0.00% | – |
Q3 2019 | $67,000 | +15.5% | 30,431 | +32.1% | 0.00% | – |
Q2 2019 | $58,000 | -35.6% | 23,045 | -11.3% | 0.00% | -100.0% |
Q1 2019 | $90,000 | +87.5% | 25,990 | +23.9% | 0.00% | – |
Q4 2018 | $48,000 | -53.4% | 20,984 | -38.0% | 0.00% | -100.0% |
Q3 2015 | $103,000 | -31.3% | 33,851 | -4.4% | 0.00% | -50.0% |
Q2 2015 | $150,000 | -3.2% | 35,425 | -12.0% | 0.00% | 0.0% |
Q1 2015 | $155,000 | -32.9% | 40,240 | +17.4% | 0.00% | -33.3% |
Q4 2014 | $231,000 | +30.5% | 34,267 | +6.4% | 0.00% | +50.0% |
Q3 2014 | $177,000 | -55.0% | 32,193 | -16.1% | 0.00% | -60.0% |
Q2 2014 | $393,000 | -42.2% | 38,377 | -32.2% | 0.01% | -44.4% |
Q1 2014 | $680,000 | +191.8% | 56,578 | +174.5% | 0.01% | +200.0% |
Q4 2013 | $233,000 | +46.5% | 20,611 | +39.8% | 0.00% | -25.0% |
Q3 2013 | $159,000 | – | 14,743 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 3,731,342 | $8,022,000 | 0.40% |
WealthTrust Axiom LLC | 210,000 | $451,000 | 0.17% |
Palo Alto Investors LP | 1,032,715 | $2,220,000 | 0.10% |
ELEMENT CAPITAL MANAGEMENT LLC | 144,536 | $311,000 | 0.06% |
SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $107,000 | 0.06% |
Joel Isaacson & Co., LLC | 70,660 | $152,000 | 0.03% |
LMR Partners LLP | 148,309 | $319,000 | 0.02% |
LINCOLN CAPITAL CORP | 10,000 | $22,000 | 0.02% |
Malaga Cove Capital, LLC | 13,150 | $28,000 | 0.02% |
Cornerstone Capital, Inc. | 30,000 | $65,000 | 0.01% |